Full metadata record
DC FieldValueLanguage
dc.creatorTomás-Velázquez, A. (Alejandra)-
dc.creatorReyes-Múgica, M. (Miguel)-
dc.creatorGonzález-Menchen, A. (Alberto)-
dc.creatorMorelló-Vicente, A. (Ana)-
dc.creatorSalido-Vallejo, R. (Rafael)-
dc.creatorAntoñanzas, J. (Javier)-
dc.creatorEstenaga, Á. (Ángela)-
dc.date.accessioned2022-04-05T08:26:59Z-
dc.date.available2022-04-05T08:26:59Z-
dc.date.issued2021-
dc.identifier.citationTomás-Velázquez, A. (Alejandra); Reyes-Múgica, M. (Miguel); González-Menchen, A. (Alberto); et al. "Neoadjuvant intralesional methotrexate for juvenile xanthogranuloma in an adult". Dermatologic Therapy. (35), 2021, e15200es
dc.identifier.issn1396-0296-
dc.identifier.urihttps://hdl.handle.net/10171/63340-
dc.description.abstractJuvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis usually occurring in infants and typically located in the head or neck.1 Clinically, solitary skin lesions are found in 60%–82% of patients and the most common variant is characterized by one yellowish nodule. Adult onset is rare, and although JXG is usually self-limiting in children, spontaneous resolution is uncommon at older ages. In addition, up to 50% of patients with spontaneous regression develop an atrophy or anetodermal area.2 Thus, complete excision is frequently performed in this population subgroup to achieve better cosmetic results. In disseminated forms, different chemotherapy regimens, corticosteroids and other systemic therapies are used. Herein, we report a case of adult JXG treated with intralesional methotrexate (MTX) resulting in a rapid reduction in size.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectDermatologyes_ES
dc.subjectJuvenile xanthogranulomaes_ES
dc.subjectAdultes_ES
dc.titleNeoadjuvant intralesional methotrexate for juvenile xanthogranuloma in an adultes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.noteThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs Licensees_ES
dc.identifier.doi10.1111-
dadun.citation.number35es_ES
dadun.citation.publicationNameDermatologic Therapyes_ES
dadun.citation.startingPagee15200es_ES

Files in This Item:
Thumbnail
File
Dermatologic Therapy - 2021 - Tom s‐Vel zquez - Neoadjuvant intralesional methotrexate for juvenile xanthogranuloma in an.pdf
Description
Size
814.1 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.